Company AB Science Deutsche Boerse AG

A8D

FR0010557264

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 11:11:08 2026-08-07 EDT			5-day change	1st Jan Change
1.100 ^EUR	+58.27%		+51.22%	-40.91%

07-13	AB Science to Discontinue Three Masitinib-related Clinical Studies	MT
07-10	AB Science streamlines its portfolio and refocuses on two molecules

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 31

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Stéphane Ledermann CEO	Chief Executive Officer	-	2026-07-06
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	64	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Stéphane Ledermann CHM	Chairman	-	2026-07-06

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
UBS Wealth Management SGIIC SA 0.004443 %	3,100	0.004443 %	3 137 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	32 638 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	20 081 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MERCK & CO., INC.	-0.04%	-1.47%	+59.62%	+20.93%	317B
MERCK KGAA	-1.03%	+0.35%	+37.33%	-10.25%	72.72B
HALOZYME THERAPEUTICS, INC.	+18.87%	+23.39%	+64.01%	+142.44%	10.17B
KYOWA KIRIN CO., LTD.	+1.29%	-3.91%	-2.66%	-2.71%	8.31B
SK BIOPHARMACEUTICALS CO., LTD.	+2.28%	+10.05%	-15.86%	-11.32%	4.6B
YUHAN CORPORATION	+3.60%	+8.92%	-29.61%	+15.14%	4.08B
BETTA PHARMACEUTICALS CO., LTD.	+14.37%	+25.87%	+1.49%	+42.79%	3.83B
SUPERNUS PHARMACEUTICALS, INC.	+0.21%	+5.19%	+13.23%	+45.57%	2.72B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+4.26%	+1.16%	-1.05%	-2.51%	2.16B
Average	+4.86%	+4.91%	+14.06%	+26.68%	47.29B
Weighted average by Cap.	+0.47%	-0.14%	+51.91%	+17.87%